A combination of two genetic tests has been shown to greatly increase the sensitivity of mesothelioma testing. Researchers at Brigham and Women's Hospital in Boston have been looking into the combination of karyotyping and fluorescence in situ hybridization (FISH) to diagnose mesothelioma. They recently studied 48 patients who were suspected of having mesothelioma.
Using the combination analysis, researchers found that the sensitivity of the test nearly doubled, reaching about 60%. This can help catch mesothelioma earlier when treatment is still a viable option. It can also be used in patients who have already undergone treatment to see how well it worked and whether or not the cancer is still present.
If you or someone you know has been diagnosed with mesothelioma, contact the Boston mesothelioma lawyers of Williams Kherkher at 800-781-3955.